CCL18 and systemic sclerosis: It can help in screening for ILD, and has good utility in evaluating disease activity and predicting prognosis in SSc-ILD.15 CCL18, previously known as macrophage inflammatory protein-4 (MIP-4), attracts naïve B lymphocytes and immature monocyte-derived dendritic cells to germinal centres.